November 27, 2012 / 7:05 AM / in 5 years

BRIEF-Abbott's Humira wins EU approval for new use

Nov 27 (Reuters) - Abbott Laboratories : * Abbott's Humira (adalimumab) approved in Europe for severe active pediatric

Crohn's disease

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below